The system provides easy-to-use, comprehensive, and automated data capture, processing and reporting capabilities. It minimizes duplication of work, eliminates error-prone manual activities, and provides extremely valuable transparency for efficient decision making, so that high-quality proteins can be delivered faster.
“Having successfully supported important workflows in biopharma discovery, we now set our sights on extending Genedata Biologics to biopharma development with an initial focus on cell line and bioprocess development,” said Dr. Othmar Pfannes, CEO of Genedata. “Our innovative platform aids in the rapid and systematic development of optimized bioprocesses, and specifically helps to standardize and streamline cell line development. This brings us another step closer in providing our customers with a fully integrated platform that supports the complete biopharmaceutical R&D process.”
ESACT Editorial Note: June 24 and 25 from 12:30 – 14:30 CEST, Genedata Biologics will present the following posters: “Genedata Biologics - An Integrated Data Management Platform for Biopharmaceutical R&D” and “Biologics Expression System Optimization and Bioprocess Development.” To schedule a briefing contact jackie.thrasivoulos(at)genedata(dot)com.
Genedata transforms data into intelligence with a portfolio of advanced software solutio
Copyright©2012 Vocus, Inc.
All rights reserved